Pancreatic Cancer Research

ResearcherQingdao UniversityActive in the last 2 years

Kejun Zhang

Matched on ORCID iD 0000-0003-0370-1462; OpenAlex author ID A5101577177. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2011: 2 papers · 2012: 3 papers · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 7

  1. RETRACTED: Chen et al. Inhibition of AKT2 Enhances Sensitivity to Gemcitabine via Regulating PUMA and NF-κB Signaling Pathway in Human Pancreatic Ductal Adenoc… Co-author DOI 10.3390/ijms27146511↗
  2. Correction: Clusterin confers gemcitabine resistance in pancreatic cancer Co-author DOI 10.1186/1477-7819-11-149↗
  3. Retraction. Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling. Co-author DOI 10.1038/labinvest.2012.138↗
  4. Apoptosis and expression of the Bcl-2 family of proteins and P53 in human pancreatic ductal adenocarcinoma. Last author DOI 10.1159/000332423↗
  5. RETRACTED: Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma. Co-author DOI 10.3390/ijms13011186↗
  6. Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling. Co-author DOI 10.1038/labinvest.2010.201↗
  7. Clusterin confers gemcitabine resistance in pancreatic cancer. Co-author DOI 10.1186/1477-7819-9-59↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dong Chen · 4 shared papers, 2011–2026 · strength 0.45
  2. Dianliang Zhang · 1 shared paper, 2026 · strength 0.36
  3. Chunping Xia · 2 shared papers, 2011–2013 · strength 0.06
  4. Qingfeng Chen · 2 shared papers, 2011–2013 · strength 0.06
  5. Dianliang Zhang · 1 shared paper, 2012 · strength 0.04
  6. Dongsheng Wang · 1 shared paper, 2012 · strength 0.03
  7. Jingyu Cao · 1 shared paper, 2011 · strength 0.03
  8. Dongsheng Wang · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.